317 related articles for article (PubMed ID: 7987834)
21. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
22. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
23. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
[TBL] [Abstract][Full Text] [Related]
24. Chemically induced tumors in transgenic mice carrying prototype human c-Ha-ras genes.
Katsuki M; Ando K; Saitoh A; Doi S; Kimura M; Takahashi R; Hasegawa T; Yokoyama M; Nomura T; Izawa M
Princess Takamatsu Symp; 1991; 22():249-57. PubMed ID: 1844246
[TBL] [Abstract][Full Text] [Related]
25. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
[TBL] [Abstract][Full Text] [Related]
26. Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands.
Wang L; Bhattacharyya N; Rabi T; Wang L; Banerjee S
Carcinogenesis; 2007 Jun; 28(6):1356-63. PubMed ID: 17166880
[TBL] [Abstract][Full Text] [Related]
27. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
28. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
Liu L; Allay E; Dumenco LL; Gerson SL
Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
[TBL] [Abstract][Full Text] [Related]
29. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
[TBL] [Abstract][Full Text] [Related]
30. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
31. Murine leukemia virus proviral insertions between the N-ras and unr genes in B-cell lymphoma DNA affect the expression of N-ras only.
Martín-Hernández J; Sørensen AB; Pedersen FS
J Virol; 2001 Dec; 75(23):11907-12. PubMed ID: 11689675
[TBL] [Abstract][Full Text] [Related]
32. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
[TBL] [Abstract][Full Text] [Related]
33. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
Jhappan C; Takayama H; Dickson RB; Merlino G
Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
[TBL] [Abstract][Full Text] [Related]
34. Intravenous vs. intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats.
Schleicher RL; Fallon MT; Austin GE; Zheng M; Zhang M; Dillehay DL; Collins DC
Prostate; 1996 Jan; 28(1):32-43. PubMed ID: 8545279
[TBL] [Abstract][Full Text] [Related]
35. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ
Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158
[TBL] [Abstract][Full Text] [Related]
36. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.
Mangues R; Seidman I; Pellicer A; Gordon JW
Oncogene; 1990 Oct; 5(10):1491-7. PubMed ID: 2174525
[TBL] [Abstract][Full Text] [Related]
37. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
38. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
39. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
40. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.
Nielsen LL; Discafani CM; Gurnani M; Tyler RD
Cancer Res; 1991 Jul; 51(14):3762-7. PubMed ID: 2065330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]